New Webcast Link to Listen to NanoXplore Webcast to Discuss Fourth Quarter and Year End Results on September 12, 2023

As previously announced NanoXplore Inc. (" NanoXplore ") (TSX: GRA and OTCQX: NNXPF) will hold a webcast to discuss the results of its fourth quarter and the year ended JuneĀ 30, 2023, on Tuesday, September 12, 2023, at 8:30 a.m. Eastern Time. Due to technical issues by the service provider, the link to listen to the live webcast has been changed; please register to the link below. The financial results will be released on Monday, September 11, 2023, after the market close.

Details of the Q4 Webcast

When : September 12, 2023, at 8:30 a.m. Eastern Time

Webcast : To listen to the live webcast, please join and register at:

https://edge.media-server.com/mmc/p/49h82hdd

or via our website under Events and Presentations in our Investors section at www.nanoxplore.ca

A replay of the event will be available at the above webcast link or in the Investors section under Events and Presentations of the Company's website at www.nanoxplore.ca .

ABOUT NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities across North America and Europe. Please visit www.nanoxplore.ca .

For further information, please contact:

Pedro Azevedo
Chief Financial Officer
Pedro.azevedo@nanoxplore.ca
Tel: +1Ā 438Ā 476Ā 1973


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CC
The Conversation (0)
LongeveronĀ® Announces Contract Development and Manufacturing Business and First Contract

LongeveronĀ® Announces Contract Development and Manufacturing Business and First Contract

Contract manufacturing services as a new business line has the potential to generate approximately $4-5 million in annual revenues First manufacturing services contract signed with Secretome Therapeutics Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company... Keep Reading...
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the "Research Group"). This study aims to evaluate the efficacy of Sona's Targeted... Keep Reading...
Why Invest in Nanotech Stocks?

Why Invest in Nanotech Stocks?

The nanotechnology market is experiencing a promising stage of growth, making it an attractive space for investors.From nanotech-based solar panels that increase energy efficiency to pharmaceutical products that make use of nanotech in drug-delivery systems, nanotechnology has far-reaching... Keep Reading...

SILO Pharma Inc

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Keep Reading...
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...

Interactive Chart

Latest Press Releases

Related News